Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site
Elyse E Lower,1 Shagufta Khan,2 Diane Kennedy,1 Robert P Baughman1 1Department of Medicine, 2Department of Pathology, University of Cincinnati Medical Center, Cincinnati, OH, USA Background: Hormone receptor and HER-2/neu discordance between the primary lesion and first metastasis has been reported...
Guardado en:
Autores principales: | Lower EE, Khan S, Kennedy D, Baughman RP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bb4a4d6d96b44518a29858549827e6a0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer
por: Salkeni MA, et al.
Publicado: (2021) -
Application of preoperative ultrasound features combined with clinical factors in predicting HER2-positive subtype (non-luminal) breast cancer
por: Jin Zhou, et al.
Publicado: (2021) -
Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance
por: Raees Tonse, et al.
Publicado: (2021) -
Prognostic Significance of Estrogen Receptor Alpha in Oral Squamous Cell Carcinoma
por: Christian Doll, et al.
Publicado: (2021) -
ASSOCIATION OF HORMONE RECEPTORS WITH RISK FACTORS AMONG BREAST CANCER PATIENTS
por: Ummara Aslam, et al.
Publicado: (2021)